{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:25:41Z","timestamp":1789500341045,"version":"build-2803163510"},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation Research"],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:p>Cardiovascular disease is the leading cause of maternal mortality in the United States, with the majority of deaths stemming from preventable causes. Contraception is one of the tools that can be utilized to prevent mortality and morbidity associated with unplanned pregnancy in patients with underlying congenital or acquired heart disease. There are a wide range of contraceptive methods available. While some methods, especially those containing estrogen, may be associated with increased risks in certain cardiac disease states, intrauterine devices, implants, and progestin-only methods may be safely used by the vast majority of patients with cardiac disease. Furthermore, intrauterine devices and implants are the most effective reversible contraceptive methods available. This review provides a summary of the US Centers for Disease Control and Prevention 2024 Medical Eligibility Criteria for Contraceptive Use as it applies to cardiac disease states. This review emphasizes the importance of contraceptive counseling and aims to familiarize the reader with the various forms of contraception available to patients, as well as the risks and benefits of each method in patients with different types of cardiac disease.<\/jats:p>","DOI":"10.1161\/circresaha.125.325682","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T18:00:22Z","timestamp":1741888822000},"page":"566-582","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease"],"prefix":"10.1161","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7747-4410","authenticated-orcid":true,"given":"Kayle","family":"Shapero","sequence":"first","affiliation":[{"name":"Brown University Health Cardiovascular Institute, Providence, RI (K.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Madden","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Science, Yale School of Medicine, New Haven, CT (T.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101382"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0803.2012.00677.x"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.025"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024229"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000911"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7304a1"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.076"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq200"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr218"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.01.051"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2019.11.003"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1363\/48e10116"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7303a1"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/13625180801942754"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000690"},{"key":"e_1_3_3_17_2","unstructured":"Guttmacher Institute. Fact Sheet: Contraceptive Effectiveness In the United States. 2020. Accessed January 30 2025. https:\/\/www.guttmacher.org\/sites\/default\/files\/factsheet\/contraceptive-effectiveness-united-states.pdf"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.02.140"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.06.006"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-198609000-00005"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2017.10.005"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2021.1975269"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199612000-00014"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.07.025"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199724"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(74)90073-0"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.05.024"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.03.010"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110855"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2023.110310"},{"key":"e_1_3_3_31_2","unstructured":"U.S. Food and Drug Administration. Annovera Prescribing Information. Accessed January 30 2025. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/209627s000lbl.pdf"},{"key":"e_1_3_3_32_2","unstructured":"Organon. NuvaRing prescribing information. 2024. Accessed January 30 2025. https:\/\/www.organon.com\/product\/usa\/pi_circulars\/n\/nuvaring\/nuvaring_pi.pdf"},{"key":"e_1_3_3_33_2","unstructured":"Mylan Pharmaceuticals Inc. Xulane prescribing information. Accessed January 30 2025. https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?type=display&setid=f7848550-086a-43d8-8ae5-047f4b9e4382"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2005.03.005"},{"key":"e_1_3_3_35_2","unstructured":"Agile therapeutics twirla prescribing information. Accessed January 30 2025. https:\/\/www.twirla.com\/hcp\/pdf\/Twirla%20FINAL%20USPI%20PPI%20IFU.pdf"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.12.007"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2023.2276668"},{"key":"e_1_3_3_38_2","unstructured":"Trost S Beauregard J Chandra G Njie F. Pregnancy-related deaths: data from maternal mortality review committees in 36 US States 2017-2019. Centers for Disease Control and Prevention US Department of Health and Human Services 2022. Accessed January 30 2025. https:\/\/www.cdc.gov\/maternal-mortality\/media\/pdfs\/Pregnancy-Related-Deaths-Data-MMRCs-2017-2019-H.pdf"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-10-200511150-00006"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(16)32484-x"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5703.203"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.769187"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1979.03300110022020"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610368670"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00264.x"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5298"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.09.027"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.02.002"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d2139"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.863612"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200039030-00005"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.05.014"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.04.014"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.110.211482"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4944"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.07.1348"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-015-0413-y"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000597"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13302-8"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1977.03270500051024"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1984.tb04747.x"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.3.483"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2024-0041"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(03)00073-8"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.7.741"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.28.2.280"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308398"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011054.pub2"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/tog.12887"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.07.012"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","unstructured":"Toffol E Heikinheimo O Jousilahti P Lehtoranta L Joensuu A Partonen T Erlund I Haukka J. Moderate associations between the use of levonorgestrel-releasing intrauterine device and metabolomics profile. 2024. doi: 10.1210\/clinem\/dgae318.","DOI":"10.1210\/clinem\/dgae318"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181b76bea"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2016.08.007"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011054.pub2"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2022.09.020"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.004941"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/524508"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000564"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.084"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.183095"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.095240"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6200.1260"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M382"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7273.1382"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH06-09-0540"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(99)00011-6"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.014"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.06.1309"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2024-002626"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.04.043"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.004"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00031.2005"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12752"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2016.6191"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.3109\/09513590009167721"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(97)00040-1"},{"key":"e_1_3_3_97_2","unstructured":"McNamara D. Impact of bromocriptine on clinical outcomes for peripartum cardiomyopathy (REBIRTH). 2024."},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2019.01.010"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.05.059"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1783\/147118903101197854"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv141"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00162-4"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201101-0078OC"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1086\/682230"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40834-018-0067-8"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd11080243"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.106164"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2021.07.058"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2013.04.003"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.144501"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004133"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022141"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05145-9"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013608"}],"container-title":["Circulation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCRESAHA.125.325682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T18:00:36Z","timestamp":1741888836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCRESAHA.125.325682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":114,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,3,14]]}},"alternative-id":["10.1161\/CIRCRESAHA.125.325682"],"URL":"https:\/\/doi.org\/10.1161\/circresaha.125.325682","relation":{},"ISSN":["0009-7330","1524-4571"],"issn-type":[{"value":"0009-7330","type":"print"},{"value":"1524-4571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"2025-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}